Civik Thomas
SEC insider (Form 3/4/5 filer). CIK 0001723092. CEO & Chairman of the Board at Pyxis Oncology, Inc. (PYXS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in BOSTON, MA.
Companies Civik Thomas has filed insider reports for
- Pyxis Oncology, Inc. (PYXS): Director, Officer, CEO & Chairman of the Board
- Repare Therapeutics Inc. (RPTX): Director
Civik Thomas
CIK: 0001723092
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 4, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
2.5M shares- - Aug 12, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
251K shares- - Feb 3, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
690.1K shares- - Jan 28, 2026RPTX
Repare Therapeutics Inc.
DispositionDirect7.5K shares- - Mar 31, 2025PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
37K shares at avg. $0.98-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 |  PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 2,503,050 | - | - | Direct |
| Aug 12, 2026 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 250,956 | - | - | Direct |
| Feb 3, 2026 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 690,131 | - | - | Direct |
| Jan 28, 2026 |  RPTX Repare Therapeutics Inc. | Disposition | 7,500 | - | $0 | Direct |
| Mar 31, 2025 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 36,979 | $0.98 | - | Direct |
1-5 of 5 transactions